Skip to main content

Nu Skin Enterprises, Inc. (NUS)

Stock NYSE

$3.80

+0.03 (+0.80%)

Delayed quote.

Price history

Daily close
NUS daily closing price, Nov 24, 2025 to Nov 20, 2026 Closed at $10.00 on Nov 24, 2025 and $3.80 on Nov 20, 2026, a change of -62.00%. Range $3.77 to $11.54.
Daily closes, Nov 24, 2025 to Nov 20, 2026 (250 trading days).
Start
$10.00
Latest close
$3.80
Period change
-62.00%
Period low
$3.77
Period high
$11.54

Key metrics

Market cap
$184.98M
Volume
794.1K
Average volume
546.7K
52-week range
$3.75 – $11.67
Beta
0.93
Last dividend
$0.24
EPS (TTM)
-$4.82
P/E ratio
2.96
Revenue (TTM)
$1.32B
Net income (TTM)
-$234.21M
Total assets
$1.09B
Total debt
$252.42M
Cash and equivalents
$164.90M

Key financials (trailing twelve months).

Company profile

Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.

Sector
Consumer Defensive
Industry
Household & Personal Products
Exchange
NYSE
CEO
Ryan S. Napierski
Employees
2,800
Headquarters
Provo, UT, US
IPO date
1996-11-22

Financial statements

Annual, last 3 fiscal years. Most recent period first. Reported in USD.

Income statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Revenue$1.49B$1.73B$1.97B
Gross profit$1.03B$1.18B$1.36B
Operating income$90.88M-$151.59M$48.27M
EBITDA$262.41M-$78.83M$204.68M
Net income$160.20M-$146.59M$8.60M
Diluted EPS$3.18-$2.95$0.17
Balance sheet
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Cash and equivalents$238.63M$186.88M$256.06M
Total assets$1.41B$1.47B$1.81B
Total liabilities$600.07M$817.46M$984.50M
Total debt$364.25M$478.23M$607.33M
Shareholders’ equity$805.24M$651.46M$821.97M
Cash flow statement
MetricFY2025Dec 31, 2025FY2024Dec 31, 2024FY2023Dec 31, 2023
Operating cash flow$80.29M$111.74M$118.64M
Capital expenditure-$34.28M-$41.58M-$58.49M
Free cash flow$46.01M$70.16M$60.15M

Quarterly, last 6 quarters. Most recent period first. Reported in USD.

Income statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Revenue$311.01M$320.11M$320.61M$370.32M$364.21M$386.14M
Gross profit$202.17M$218.32M$214.46M$261.98M$256.72M$265.73M
Operating income$5.09M-$59.32M$5.87M$23.24M$21.64M$30.78M
EBITDA$24.20M-$47.20M$19.19M$35.10M$32.23M$42.99M
Net income-$742.0K-$249.80M$1.84M$14.49M$17.08M$21.12M
Diluted EPS-$0.02-$5.14$0.04$0.29$0.34$0.43
Balance sheet
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Cash and equivalents$164.90M$189.64M$198.65M$238.63M$251.79M$264.16M
Total assets$1.09B$1.12B$1.38B$1.41B$1.42B$1.44B
Total liabilities$540.60M$578.79M$582.71M$600.07M$624.61M$655.94M
Total debt$252.42M$263.74M$277.61M$364.25M$291.43M$310.74M
Shareholders’ equity$547.48M$542.74M$794.09M$805.24M$799.79M$787.75M
Cash flow statement
MetricQ3 2026Sep 30, 2026Q2 2026Jun 30, 2026Q1 2026Mar 31, 2026Q4 2025Dec 31, 2025Q3 2025Sep 30, 2025Q2 2025Jun 30, 2025
Operating cash flow-$8.12M$10.62M-$3.92M$16.62M$27.48M$35.80M
Capital expenditure-$11.35M-$5.64M-$13.71M-$10.76M-$9.91M-$18.0K
Free cash flow-$19.47M$4.99M-$17.63M$5.86M$17.57M$35.78M